Libivirumab
Based on 1 Customer Validation
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively.
For research use only. We do not sell to patients.
- Purity : 98.27%
- CAS No.: 569658-79-3
- Molecular Weight:149.04 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
HBV
In Vitro
Libivirumab (0-500 ng/mL) shows neutralization activity in HepG2-NTCP cells with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
ELISA, FACS, Functional assay
Product Details
-
CAS No. 569658-79-3
-
Accession P05231
-
Synonyms 17.1.41
-
Molecular Weight 149.04 kDa
-
Species Reactivity
Virus
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
98.27%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)